Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of topical NSAIDs for non-specific low back pain
ChiCTR2100050243Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Yunnan Province
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of loxoprofen and flurbiprofen in non-specific low back pain (NSLBP) and chronic low back pain (CLBP) (2 arms), sponsored by The First People's Hospital of Yunnan Province. Primary endpoint: Total effective rate of treatment. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
loxoprofenflurbiprofen
03
Conditions
non-specific low back pain (NSLBP)chronic low back pain (CLBP)
Beyond the preview
Go deeper on ChiCTR2100050243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050243.